| Sos-bridges Health Center | |
|
1000 N Kraemer Pl Ste 204 Anaheim CA 92806-2610 | |
| (949) 270-2100 | |
| (949) 650-4458 |
| Full Name | Sos-bridges Health Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 1000 N Kraemer Pl Ste 204, Anaheim, California |
| Authorized Official Name and Position | Christy Ward (CEO) |
| Authorized Official Contact | 9495363927 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Sos-bridges Health Center Po Box 10159 Costa Mesa CA 92627-0050 Ph: (949) 270-2100 | Sos-bridges Health Center 1000 N Kraemer Pl Ste 204 Anaheim CA 92806-2610 Ph: (949) 270-2100 |
| NPI Number | 1184279952 |
|---|---|
| Provider Enumeration Date | 08/07/2019 |
| Last Update Date | 07/29/2020 |
| Medicare PECOS PAC ID | 4789854993 |
|---|---|
| Medicare Enrollment ID | O20200728001441 |
News Archive
Pearl Therapeutics Inc., a company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from a Phase 1 safety and pharmacokinetics study of PT003, its lead combination therapeutic for the treatment of chronic obstructive pulmonary disease (COPD). Based on these results, and previously announced positive results from Phase 2a studies of PT003's individual components, the company has advanced PT003 into a Phase 2b trial.
In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.
Adults from underrepresented racial groups who have acute heart blockages and cardiac arrests received fewer early interventions, had longer hospital stays and higher death rates than their white counterparts, according to preliminary research to be presented at the American Heart Association's Resuscitation Science Symposium 2020.
With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184279952 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
Pearl Therapeutics Inc., a company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from a Phase 1 safety and pharmacokinetics study of PT003, its lead combination therapeutic for the treatment of chronic obstructive pulmonary disease (COPD). Based on these results, and previously announced positive results from Phase 2a studies of PT003's individual components, the company has advanced PT003 into a Phase 2b trial.
In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.
Adults from underrepresented racial groups who have acute heart blockages and cardiac arrests received fewer early interventions, had longer hospital stays and higher death rates than their white counterparts, according to preliminary research to be presented at the American Heart Association's Resuscitation Science Symposium 2020.
With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.
› Verified 3 days ago
The Family Medicine Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1211 W. La Palma Avenue, Suite #404, Anaheim, CA 92801 Phone: 714-772-1030 Fax: 714-772-1758 | |
Anaheim Medical Group Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2571 W La Palma Ave, Anaheim, CA 92801 Phone: 714-827-9797 Fax: 714-827-5377 | |
Shirdi Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1751 W Romneya Dr, Anaheim, CA 92801 Phone: 714-776-3180 Fax: 714-991-1932 | |
Rakesh Kumar Bhola ,m.d. Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1781 W Romneya Dr Ste C, Anaheim, CA 92801 Phone: 714-776-2700 | |
Anaheim Health Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1125 N Magnolia Ave, Anaheim, CA 92801 Phone: 714-484-1280 Fax: 714-484-1358 | |
Richard Dick M Yip Md A Medical Corp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 408 S Beach Blvd Ste 211, Anaheim, CA 92804 Phone: 714-527-6000 Fax: 714-527-2371 | |
Benevolence Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 303 N East St, Anaheim, CA 92805 Phone: 714-491-1771 |